Psoriatic Arthritis

Ixekizumab Shows Benefit in Patients With Psoriatic Arthritis and Inadequate TNFi Response

February 23, 2021

Generally, guidelines recommend beginning psoriatic arthritis (PsA) treatment with tumor necrosis factor inhibitors (TNFis). However, not all patients respond to this method. Ixekizumab (IXE) improved the signs and symptoms of PsA in patients who had exhibited inadequate response to 1 or 2 TNFis.

Apremilast Tablets Approved by FDA as a Generic for Psoriatic Arthritis

February 17, 2021

The drug is commonly used to treat diseases such as psoriatic arthritis, Behcet’s Syndrome, and plaque psoriasis.

Etanercept Shows Greater Improvements in Treating Psoriatic Arthritis Than MTX Monotherapy

February 05, 2021

In this 48-week, phase 3, randomized controlled trial, investigators examined patient-reported outcomes of patients with psoriatic arthritis receiving methotrexate monotherapy, etanercept monotherapy, or a combination of both drugs.

TNF Inhibitor Use in Psoriatic Arthritis Does Not Increase Solid Cancer Risk

January 27, 2021

Investigators determined, “Treatment with TNF inhibitors is not associated with increased risks of solid cancer overall, or eight common cancer types. There were no indications of different crude incidence of solid cancers overall by TNF inhibitor agent.”

If Remission Is Our Goal, Rheumatology Must Embrace the Importance of Studying New Mechanisms

January 25, 2021

Alyssa Johnsen, MD, PhD, shares her insight on the importance of understanding key pathways that drive immune-mediated diseases, which can help rheumatologists develop more potent and specific therapies for patients with rheumatic disease.

Secukinumab Improves Axial Disease in Psoriatic Arthritis

January 21, 2021

Improvement in ASAS20 (Assessment of SpondyloArthritis international Society) was seen in 63% of participants assigned to secukinumab 300 mg and 66% of those assigned to secukinumab 150 mg, versus 31% of the placebo group.

Diagnostic Imaging Shows Increasing Promise for Improving Diagnosis and Care of Psoriatic Arthritis

December 23, 2020

Some of the latest developments in the use of these diagnostic tools for psoriatic arthritis were presented the annual meeting of the American College of Rheumatology Convergence 2020 in November.

Patients With Psoriatic Arthritis May Benefit From Tofacitinib Monotherapy

December 14, 2020

Patients who had received tofacitinib combination therapy may be able to discontinue methotrexate.

Early Diagnosis in Psoriatic Arthritis Is Often Missed

November 24, 2020

More than half of patients with psoriatic arthritis have to wait two or more years for a diagnosis, researchers report.

Fewer Than Half of Psoriatic Arthritis Patients Report Obvious Side Effects

November 24, 2020

Many patients with psoriatic arthritis live with unacceptable levels of disease activity despite treatment, and patient-reported outcomes could provide useful treatment targets, shows a new study.